bpc-157 human clinical trials safety adverse effects FDA's Review Of Peptides Signals A Growing Public Health Challenge BPC-157 as a Healing Peptide

The most common side effects are gastrointestinal symptoms nausea, vomiting, diarrhea, and constipation

Thus, from a scientific point of view, dietary supplements are urgently recommended for this group of people

BPC-157 Synthetic peptide studied in animal and cell models for tissue healing and gastric cytoprotection Last updated: March 1, 2026 Compound BPC-157 Class Recovery peptide Summary Synthetic peptide studied in animal and cell models for tissue healing, gastric cytoprotection, anti-inflammatory action

[4] Waschek JA

For now, retatrutide remains in clinical trials with uncertain approval timeline

Researchers should consult primary literature (Sikiric et al., 2010-2020) for protocol-specific concentrations